- Jul 25
Take a Shot on Pfizer
In 2023, Pfizer paid $43 billion to acquire Seagen, a company that specializes in cancer medications.
- Jul 18
Expect Stocks to Rally between Convention Season & Inauguration
We treat a market correction during an election to be a buying opportunity for our clients.
- Jul 11
Franco-Nevada is a Golden Opportunity
FNV receives a percentage of revenue yet isn’t on the hook for paying any of the expenses or cost overruns that often plague a mine.
- Jul 3
Could the AI Stocks Follow Cisco’s Fortune?
Investing in companies with very optimistic future growth rates accompanies high risk and high reward.